Company intelligence / Profile preview
EVE Medical Systems Ltd.
Israel
- Ownership
- Private
- Development stage
- Other
01
Overview
The company has developed a proprietary diagnostic and therapeutic system for identifying sensitivity to female sex hormones using a skin test panel. Women identified as sensitive are treated with intradermal hormone injections to induce tolerance. Two Phase 2 clinical trials have been conducted targeting severe PMS and unexplained recurrent pregnancy loss, but no published results or approvals yet.
- Therapeutic areas
- Women's Health
- Modalities
- Immunomodulators (hormone desensitization therapy)
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on EVE Medical Systems Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EVE Medical Systems Ltd..